Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.
Fabio Romerio
, Davide Zella
Research output
:
Contribution to journal
›
Article
›
peer-review
61
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Interferon-alpha2b
100%
Extracellular Signal-Regulated MAP Kinases
57%
Mitogens
53%
Interferon-alpha
42%
Phosphotransferases
41%
Cyclin-Dependent Kinase 2
15%
Cyclin-Dependent Kinase 4
15%
Cyclin D
14%
Cell Proliferation
14%
Cyclin E
13%
Cell Cycle Resting Phase
12%
G1 Phase
11%
Hematologic Neoplasms
10%
S Phase
10%
Interleukin-2
9%
Antiviral Agents
9%
Cell Cycle
8%
Cytokines
6%
T-Lymphocytes
6%
Growth
5%
Neoplasms
3%
Chemical Compounds
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
85%
Phosphotransferase Inhibitor
67%
Additive
35%
Molecule
18%